Patent ID: 11873281
Assignee: HANGZHOU DAC BIOTECH CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A  C

Claim 6:
7. The conjugate according to claim 1 having Formula (VII):, or a pharmaceutically acceptable salt, hydrate, or hydrated salt; or a polymorphic crystalline structure thereof, or an optical isomer, racemate, diastereomer or enantiomer thereof, wherein T, L, n, m, Y, R1, R1′, R2, R3, R4, R6, R8, R10, R11, and R12 are defined the same as in Formula (I);
wherein R13 is C1˜C10 alkyl, heteroalkyl, alkyl acid, alkyl amide, alkyl amine, or Ar; Ar refers to a aromatic or hetero aromatic group, composed of one or several rings, comprising four to ten carbon atoms; the hetero aromatic group is an aromatic group wherein one, or more carbon atoms are replaced by O, N, Si, Se, P or S, the aryl or Ar is an aromatic group, wherein one or several H atoms are replaced independently by R18, F, Cl, Br, I, OR16, SR16; NR16R18, N═NR16, N═R16, NR16R18, NO2, SOR16R18, SO2R16, SO3R16, OSO3R16, PR16R18, POR16R18, PO2R16R18, OPO3R16R18, or PO3R16R18 wherein R16 and R18 are independently H, C1˜C8 alkyl; C2˜C8 alkenyl, alkynyl, or heteroalkyl; C3˜C8 aryl, heterocyclic, carbocyclic, cycloalkyl, alkylcycloalkyl, heterocycloalkyl, heteroaralkyl, heteroalkylcycloalkyl, or alkylcarbonyl; or C4˜C12 glycoside; or a pharmaceutical salt.